The role of nonsense-mediated decay in neuronal ceroid lipofuscinosis

Human Molecular Genetics

Volumn 22, Issue 13, 2013, Pages 2723-2734

  Miller, Jake N ^a,b   Chan, Chun Hung ^a   Pearce, David A ^a,b  

^a SANFORD RESEARCH   (United States)

^b UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DISEASE CONTROL; DISEASE COURSE; ENZYME ACTIVITY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HETEROZYGOTE; LYMPHOBLAST; MOLECULARLY TARGETED THERAPY; NEURONAL CEROID LIPOFUSCINOSIS; NONSENSE MEDIATED MRNA DECAY; NONSENSE MUTATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; RNA DEGRADATION; STOP CODON;

AMINOPEPTIDASES; CELL LINE; CODON, NONSENSE; DIPEPTIDYL-PEPTIDASES AND TRIPEPTIDYL-PEPTIDASES; ENZYME ACTIVATION; GENE ORDER; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MOLECULAR CHAPERONES; MUTATION; NEURONAL CEROID-LIPOFUSCINOSES; NONSENSE MEDIATED MRNA DECAY; PROTEOLYSIS; RNA, MESSENGER; SERINE PROTEASES; THIOLESTER HYDROLASES; TRANSCRIPTION, GENETIC;

EID: 84878903162     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt120     Document Type: Article

References (54)

1. Haltia, M. (2003) The neuronal ceroid-lipofuscinoses. J. Neuropathol. Exp. Neurol., 62, 1-13.
2. Santavuori, P. (1988) Neuronal ceroid-lipofuscinoses in childhood. Brain Dev., 10, 80-83.
3. Jalanko, A. and Braulke, T. (2009) Neuronal ceroid lipofuscinoses. BBA Mol. Cell. Res., 1793, 697-709.
4. Arsov, T., Smith, K.R., Damiano, J., Franceschetti, S., Canafoglia, L., Bromhead, C.J., Andermann, E., Vears, D.F., Cossette, P., Rajagopalan, S. et al. (2011) Kufs disease, the major adult form of neuronal ceroid lipofuscinosis, caused by mutations in CLN6. Am. J. Hum. Genet., 88, 566-573.
5. Bras, J., Verloes, A., Schneider, S.A., Mole, S.E. and Guerreiro, R.J. (2012) Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis. Hum. Mol. Genet., 21, 2646-2650.
6. Kousi, M., Lehesjoki, A.E. and Mole, S.E. (2012) Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses. Hum. Mutat., 33, 42-63.
7. Noskova, L., Stranecky, V., Hartmannova, H., Pristoupilova, A., Baresova, V., Ivanek, R., Hulkova, H., Jahnova, H., van der Zee, J., Staropoli, J.F. et al. (2011) Mutations in DNAJC5, encoding cysteine-string protein alpha, cause autosomal-dominant adult-onset neuronal ceroid lipofuscinosis. Am. J. Hum. Genet., 89, 241-252.
8. Chan, C.H., Mitchison, H.M. and Pearce, D.A. (2008) Transcript and in silico analysis of CLN3 in juvenile neuronal ceroid lipofuscinosis and associated mouse models. Hum. Mol. Genet., 17, 3332-3339.
9. Chang, Y.-F., Imam, J.S. and Wilkinson, M.F. (2007) The nonsense-mediated decay RNA surveillance pathway. Annu. Rev. Biochem., 76, 51-74.
10. Hwang, J., Sato, H., Tang, Y., Matsuda, D. and Maquat, L.E. (2010) UPF1 association with the cap-binding protein, CBP80, promotes nonsense-mediated mRNA decay at two distinct steps. Mol. Cell., 39, 396-409.
11. Hwang, J. and Maquat, L.E. (2011) Nonsense-mediated mRNA decay (NMD) in animal embryogenesis: to die or not to die, that is the question. Curr. Opin. Genet. Devel., 21, 422-430.
12. Isken, O., Kim, Y.K., Hosoda, N., Mayeur, G.L., Hershey, J.W. and Maquat, L.E. (2008) Upf1 phosphorylation triggers translational repression during nonsense-mediated mRNA decay. Cell, 133, 314-327.
13. Lee, H.C., Oh, N., Cho, H., Choe, J. and Kim, Y.K. (2010) Nonsense-mediated translational repression involves exon junction complex downstream of premature translation termination codon. FEBS Lett., 584, 795-800.
14. Muhlemann, O., Eberle, A., Stalder, L. and Zamudioorozco, R. (2008) Recognition and elimination of nonsense mRNA. BBA - Gene Reg. Mech., 1779, 538-549.
15. Silva, A.L. and Romao, L. (2009) The mammalian nonsense-mediated mRNA decay pathway: to decay or not to decay! Which players make the decision? FEBS Lett., 583, 499-505.
16. Kervestin, S. and Jacobson, A. (2012) NMD: a multifaceted response to premature translational termination. Nature Rev. Mol. Cell Biol., 13, 700-712.
17. Brooks, D.A., Muller, V.J. and Hopwood, J.J. (2006) Stop-codon read-through for patients affected by a lysosomal storage disorder. Trends Mol. Med., 12, 367-373.
18. Finkel, R.S. (2010) Read-through strategies for suppression of nonsense mutations in Duchenne/Becker muscular dystrophy: aminoglycosides and ataluren (PTC124). J. Child. Neurol., 25, 1158-1164.
19. Goldmann, T., Overlack, N., Wolfrum, U. and Nagel-Wolfrum, K. (2011) PTC124-mediated translational readthrough of a nonsense mutation causing usher syndrome type 1C. Hum. Gene Ther., 22, 537-547.
20. Lee, H.L. and Dougherty, J.P. (2012) Pharmaceutical therapies to recode nonsense mutations in inherited diseases. Pharmacol. Ther., 136, 227-266.
21. Welch, E.M., Barton, E.R., Zhuo, J., Tomizawa, Y., Friesen, W.J., Trifillis, P., Paushkin, S., Patel, M., Trotta, C.R., Hwang, S. et al. (2007) PTC124 targets genetic disorders caused by nonsense mutations. Nature, 447, 87-91.
22. Kayali, R., Ku, J.-M., Khitrov, G., Jung, M.E., Prikhodko, O. and Bertoni, C. (2012) Read-through compound 13 restores dystrophin expression and improves muscle function in the mdx mouse model for Duchenne muscular dystrophy. Hum. Mol. Genet., 21, 4007-4020.
23. Lewis, B.P., Green, R.E. and Brenner, S.E. (2003) Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proc. Natl Acad. Sci. USA, 100, 189-192.
24. Frischmeyer, P.A. and Dietz, H.C. (1999) Nonsense-mediated mRNA decay in health and disease. Hum. Mol. Genet., 8, 1893-1900.
25. Holbrook, J.A., Neu-Yilik, G., Hentze, M.W. and Kulozik, A.E. (2004) Nonsense-mediated decay approaches the clinic. Nat. Genet., 36, 801-808.
26. Stehlikova, K., Zapletalova, E., Sedlackova, J., Hermanova, M., Vondracek, P., Marikova, T., Mazanec, R., Zamecnik, J., Vohanka, S. and Fajkus, J. (2007) Quantitative analysis of CAPN3 transcripts in LGMD2A patients: involvement of nonsense-mediated mRNA decay. Neuromuscul. Disord., 17, 143-147.
27. Kerr, T.P., Sewry, C.A., Robb, S.A. and Roberts, R.G. (2001) Long mutant dystrophins and variable phenotypes: evasion of nonsense-mediated decay? Hum. Genet., 109, 402-407.
28. Williams, R.E. and Mole, S.E. (2012) New nomenclature and classification scheme for the neuronal ceroid lipofuscinoses. Neurology, 79, 183-191
29. Das, A.K., Becerra, C.H., Yi, W., Lu, J.Y., Siakotos, A.N., Wisniewski, K.E. and Hofmann, S.L. (1998) Molecular genetics of palmitoyl-protein thioesterase deficiency in the U.S. J. Clin. Invest., 102, 361-370.
30. Mitchison, H.M., Hofmann, S.L., Becerra, C.H., Munroe, P.B., Lake, B.D., Crow, Y.J., Stephenson, J.B., Williams, R.E., Hofman, I.L., Taschner, P.E. et al. (1998) Mutations in the palmitoyl-protein thioesterase gene (PPT; CLN1) causing juvenile neuronal ceroid lipofuscinosis with granular osmiophilic deposits. Hum. Mol. Genet., 7, 291-297.
31. Mole, S.E., Zhong, N.A., Sarpong, A., Logan, W.P., Hofmann, S., Yi, W., Franken, P.F., van Diggelen, O.P., Breuning, M.H., Moroziewicz, D. et al. (2001) New mutations in the neuronal ceroid lipofuscinosis genes. Euro. J. Paediatr. Neurol., 5(Suppl A), 7-10.
32. Bellizzi, J.J. III, Widom, J., Kemp, C., Lu, J.Y., Das, A.K., Hofmann, S.L. and Clardy, J. (2000) The crystal structure of palmitoyl protein thioesterase 1 and the molecular basis of infantile neuronal ceroid lipofuscinosis. Proc. Natl Acad. Sci. USA, 97, 4573-4578.
33. Ohno, K., Saito, S., Sugawara, K., Suzuki, T., Togawa, T. and Sakuraba, H. (2010) Structural basis of neuronal ceroid lipofuscinosis 1. Brain Dev., 32, 524-530.
34. Sleat, D.E., Gin, R.M., Sohar, I., Wisniewski, K., Sklower-Brooks, S., Pullarkat, R.K., Palmer, D.N., Lerner, T.J., Boustany, R.M., Uldall, P. et al. (1999) Mutational analysis of the defective protease in classic late-infantile neuronal ceroid lipofuscinosis, a neurodegenerative lysosomal storage disorder. Am. J. Hum. Genet., 64, 1511-1523.
35. Pal, A., Kraetzner, R., Gruene, T., Grapp, M., Schreiber, K., Gronborg, M., Urlaub, H., Becker, S., Asif, A.R., Gartner, J. et al. (2009) Structure of tripeptidyl-peptidase I provides insight into the molecular basis of late infantile neuronal ceroid lipofuscinosis. J. Biol. Chem., 284, 3976-3984.
36. Steinfeld, R., Steinke, H.B., Isbrandt, D., Kohlschutter, A. and Gartner, J. (2004) Mutations in classical late infantile neuronal ceroid lipofuscinosis disrupt transport of tripeptidyl-peptidase I to lysosomes. Hum. Mol. Genet., 13, 2483-2491.
37. Mole, S.E. (2004) The genetic spectrum of human neuronal ceroid-lipofuscinoses. Brain Pathol., 14, 70-76.
38. Mole, S.E., Williams, R.E. and Goebel, H.H. (2005) Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses. Neurogenetics, 6, 107-126.
39. Siintola, E., Lehesjoki, A.E. and Mole, S.E. (2006) Molecular genetics of the NCLs-status and perspectives. Biochim. Biophys. Acta, 1762, 857- 864.
40. Phillips, S.N., Benedict, J.W., Weimer, J.M. and Pearce, D.A. (2005) CLN3, the protein associated with batten disease: structure, function and localization. J. Neurosci. Res., 79, 573-583.
41. Voznyi, Y.V., Keulemans, J.L., Mancini, G.M., Catsman-Berrevoets, C.E., Young, E., Winchester, B., Kleijer, W.J. and van Diggelen, O.P. (1999) A new simple enzyme assay for pre- and postnatal diagnosis of infantile neuronal ceroid lipofuscinosis (INCL) and its variants. J. Med. Genet., 36, 471-474.
42. van Diggelen, O.P., Keulemans, J.L.M., Winchester, B., Hofman, I.L., Vanhanen, S.L., Santavuori, P. and Voznyi, Y.V. (1999) A rapid fluorogenic palmitoyl-protein thioesterase assay: pre- and postnatal diagnosis of INCL. Mol. Genet. Metab., 66, 240-244.
43. van Diggelen, O.P., Thobois, S., Tilikete, C., Zabot, M.-T., Keulemans, J.L.M., van Bunderen, P.A., Taschner, P.E., Losekoot, M. and Voznyi, Y.V. (2001) Adult neuronal ceroid lipofuscinosis with palmitoyl-protein thioesterase deficiency: first adult-onset patients of a childhood disease. Ann. Neurol., 50, 269-272.
44. Sohar, I., Sleat, D.E., Jadot, M. and Lobel, P. (1999) Biochemical characterization of a lysosomal protease deficient in classical late infantile neuronal ceroid lipofuscinosis (LINCL) and development of an enzyme-based assay for diagnosis and exclusion of LINCL in human specimens and animal models. J. Neurochem., 73, 700-711.
45. Sohar, I., Lin, L. and Lobel, P. (2000) Enzyme-based diagnosis of classical late infantile neuronal ceroid lipofuscinosis: comparison of tripeptidyl peptidase i and pepstatin-insensitive protease assays. Clin. Chem., 46, 1005-1008.
46. Das, A.K., Lu, J.Y. and Hofmann, S.L. (2001) Biochemical analysis of mutations in palmitoyl-protein thioesterase causing infantile and late-onset forms of neuronal ceroid lipofuscinosis. Hum. Mol. Genet., 10, 1431-1439.
47. Sleat, D.E., Sohar, I., Gin, R.M. and Lobel, P. (2001) Aminoglycoside-mediated suppression of nonsense mutations in late infantile neuronal ceroid lipofuscinosis. Euro. J. Paediatr. Neurol., 5 (Suppl A), 57-62.
48. Sarkar, C., Zhang, Z. and Mukherjee, A.B. (2011) Stop codon read-through with PTC124 induces palmitoyl-protein thioesterase-1 activity, reduces thioester load and suppresses apoptosis in cultured cells from INCL patients. Mol. Genet. Metab., 3, 383-345.
49. Beck, M. (2007) New therapeutic options for lysosomal storage disorders: enzyme replacement, small molecules and gene therapy. Hum. Genet., 121, 1-22.
50. Sands, M.S. and Davidson, B.L. (2006) Gene therapy for lysosomal storage diseases. Mol. Ther., 13, 839-849.
51. Kohan, R., Cismondi, I.A., Oller-Ramirez, A.M., Guelbert, N., Anzolini, T.V., Alonso, G., Mole, S.E., de Kremer, D.R. and de Halac, N.I. (2011) Therapeutic approaches to the challenge of neuronal ceroid lipofuscinoses. Curr. Pharm. Biotechnol., 12, 867-883.
52. Ramirez-Montealegre, D. and Pearce, D.A. (2005) Defective lysosomal arginine transport in juvenile Batten disease. Hum. Mol. Genet., 14, 3759-3773.
53. Pfaffl, M.W. (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res., 29, e45.
54. Pfaffl, M.W., Horgan, G.W. and Dempfle, L. (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res., 30, e36.